SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
伯赏凝旋
Lv1
8
46 积分
2022-07-13 加入
最近求助
最近应助
互助留言
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
18小时前
已完结
Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study
19小时前
已完结
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study
19小时前
已完结
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2天前
已完结
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis
2天前
已完结
Autoimmune hemolytic anemia (AIHA) associated with chronic lymphocytic leukemia in the current era of targeted therapy
5天前
已完结
New Therapies for the Treatment of Warm Autoimmune Hemolytic Anemia
6天前
已完结
奥布替尼治疗多种免疫抑制剂无效且合并感染的自身免疫性溶血性贫血1例
6天前
已关闭
Clinical utility of circulating tumor DNA in patients with advanced KRASG12C-mutated non-small cell lung cancer treated with sotorasib
7天前
已完结
Clinical utility of circulating tumor DNA in patients with advanced KRASG12C-mutated non-small cell lung cancer treated with sotorasib
7天前
已关闭
[The relationship between the variants in 5' upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang]
1年前
已采纳
找不到【积分已退回】
6天前
重新求助【积分已退回】
7天前
重新求助【积分已退回】
7天前
找到了【积分已退回】
7天前
不找了【积分已退回】
16天前
重新求助【积分已退回】
1个月前
找不到了【积分已退回】
1个月前
不要了【积分已退回】
1个月前
找到了【积分已退回】
1个月前
找到了【积分已退回】
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论